Navigation Links
Sun or shade: Pecan leaves' photosynthetic light response evaluated
Date:11/3/2009

COLLEGE STATION, TXPecan, the most valuable nut tree native to North America, is native from northern Illinois and southeastern Iowa to the Gulf Coast of the United States, where it grows abundantly along the Mississippi River, the rivers of central and eastern Oklahoma, and Texas. Popularity and consumer demand for pecans has increased the cultivation of pecan trees to other areas, while commercial production has expanded into many regions of the United States and Mexico.

Effective management of the tree canopy is of vital interest to pecan growers. Pecan trees require careful canopy management to avoid self-shading and to maintain productivity. Leaves of pecan trees typically intercept 65% to 70% of available sunlight with up to 95% light interception in overcrowded, unpruned orchards; less light naturally affects photosynthesis. To improve the amount of light penetration, pecan growers commonly use pruning techniques to increase photosynthesis and flowering on trees. To date, however, little information has been available to growers about the change in photosynthesis activity of pecan leaves throughout the growing season.

Leonardo Lombardini, Hermann Restrepo-Diaz, and Astrid Volder of Texas A&M University's Department of Horticultural Sciences published the results of an experiment using pecan tree cultivars in a recent issue of the Journal of the American Society for Horticultural Science. According to Lombardini and collaborators, the objective of the experiment was to quantify the effects of differences in light intensity on the "morphological characteristics and seasonal physiological performance of sun and shade leaves of field-grown pecan trees".

The experiment was conducted during the 2007 growing season at Texas A&M University. The cultivars used for the research, 'Pawnee' and 'Stuart', were chosen because of their rank as two of the most important pecan varieties for commercial growers.

Treatments were
'/>"/>

Contact: Michael W. Neff
mwneff@ashs.org
703-836-4606
American Society for Horticultural Science
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Bird flu leaves the nest -- adapting to a new host
2. Why are autumn leaves red in America and yellow in Europe?
3. The hepatitis healing power of blueberry leaves
4. A win-win: U-pick pumpkin farms recycle urban leaves
5. When leaves fall, more is occurring than a change of weather
6. From Canada to the Caribbean: Tree leaves control their own temperature, Penn study reveals
7. Aquaculture concept leaves judges goggle eyed
8. Why do autumn leaves bother to turn red?
9. Orientation of antenna protein in photosynthetic bacteria described
10. Berkeley researchers identify photosynthetic dimmer switch
11. Researchers decode genetics of rare photosynthetic bacterium
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sun or shade: Pecan leaves' photosynthetic light response evaluated
(Date:5/11/2015)... 11, 2015 Curemark LLC, a privately held ... a new Phase III double blind, randomized, placebo-controlled clinical ... CM-AT, on all children ages 3-8 with Autism. Previously, ... III double blinded clinical trial for CM-AT in children ... the digestive enzyme chymotrypsin. This new trial will help ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... plate may soon take on a literal meaning. Diane Bisson, ... Design, has fashioned edible plates that are practical, stylish and ... which has resulted in a book highlighting more than 50 ... Material. "The idea of using food to support a ...
... of Georgia scientists looking to understand the genetic mechanisms ... first time in plants an inverse relationship between gene ... diversity not only in plants, but in animals and ... this week,s Proceedings of the National Academy of ...
... , , TORONTO, Dec. 7 ... acquired the assets of the healthcare communications company previously operating ... now move forward under new leadership and funding. , IgeaCare ... of Chief Executive Officer. Under his direction, the new company ...
Cached Biology News:Plate-eating good: Université de Montréal professor designs edible tableware 2Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2
(Date:5/21/2015)... -- Prima Biomed Ltd. (NASDAQ: PBMD ) a globally ... leader in the development of immunotherapeutic products for the ... data from the Phase II CAN-003 ovarian cancer clinical ... meaningful improvement in Overall Survival ("OS") over standard of ... the group of second remission patients (n=20), the median ...
(Date:5/21/2015)... 2015 W. R. Grace & ... in Worms, Germany has received good manufacturing practice ... the International Pharmaceutical Excipient Council (IPEC) Foundation. ... its SYLOID® FP brand of pharmaceutical grade excipient ... the Curtis Bay, Maryland (USA) and Sorocaba, Brazil ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
... - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ... today announced the filing of its audited,consolidated financial ... ended December 31, 2007 and the restatement of ... December 31, 2006., For the year ended ...
... Calif., March 13 Bionovo, Inc.,(Nasdaq: BNVI ... Ph.D., to,the company,s Board of Directors. Dr. Butler ... and in particular in,advancing cancer drug development and ... have George on board as we move into ...
... LEUVEN, Belgium, March 13 ThromboGenics NV,(Euronext Brussels: ... announces a business update and its financial results ... During this period,ThromboGenics has raised additional funds to ... make good progress with its clinical,programs., Highlights, ...
Cached Biology Technology:Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 2Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 3Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 4Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 5Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 6Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 7Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 8Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006 9George Butler Joins Bionovo's Board of Directors 2George Butler Joins Bionovo's Board of Directors 3ThromboGenics Announces 2007 Full Year Results 2ThromboGenics Announces 2007 Full Year Results 3ThromboGenics Announces 2007 Full Year Results 4
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
... kit for 25 chips provides the chips ... analysis (at picogram levels) with the Experion ... RNA HighSens microfluidic chips, 2 x 1,250 ... RNA HighSens stain, 20 microliters RNA ladder, ...
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
... kit provides all the accessories necessary for ... conformation polymorphism analysis (SSCP) with the DCode ... a cooling finger adaptor for use with ... of 20 cm plates, 2 sets of ...
Biology Products: